These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25537341)

  • 41. High and low doses of clarithromycin treatment are associated with different clinical efficacies and immunomodulatory properties in chronic rhinosinusitis.
    Fan Y; Xu R; Hong H; Luo Q; Xia W; Ding M; Shi J; Lv M; Li H
    J Laryngol Otol; 2014 Mar; 128(3):236-41. PubMed ID: 24555753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate for the treatment of inflammatory lung diseases: An in vitro study.
    Fallacara A; Busato L; Pozzoli M; Ghadiri M; Ong HX; Young PM; Manfredini S; Traini D
    Eur J Pharm Sci; 2018 Jul; 120():96-106. PubMed ID: 29723596
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional and cytometric examination of different human lung epithelial cell types as drug transport barriers.
    Min KA; Rosania GR; Kim CK; Shin MC
    Arch Pharm Res; 2016 Mar; 39(3):359-69. PubMed ID: 26746641
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TPP-dendrimer nanocarriers for siRNA delivery to the pulmonary epithelium and their dry powder and metered-dose inhaler formulations.
    Bielski E; Zhong Q; Mirza H; Brown M; Molla A; Carvajal T; da Rocha SRP
    Int J Pharm; 2017 Jul; 527(1-2):171-183. PubMed ID: 28549971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formulation of rifampicin-cyclodextrin complexes for lung nebulization.
    Tewes F; Brillault J; Couet W; Olivier JC
    J Control Release; 2008 Jul; 129(2):93-9. PubMed ID: 18514353
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
    Togami K; Chono S; Morimoto K
    J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of a general in vitro approach for prediction of total lung deposition in healthy adults for pharmaceutical inhalation products.
    Olsson B; Borgström L; Lundbäck H; Svensson M
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):355-69. PubMed ID: 23421897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells.
    Togami K; Chono S; Morimoto K
    Pharmazie; 2012 May; 67(5):389-93. PubMed ID: 22764569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of fine particulate matter (SRM 2786) on three different 3D lung models exposed at the air-liquid interface - A comparative study.
    Grytting VS; Skuland T; Ballangby J; Refsnes M; Låg M; Øvrevik J; Mariussen E
    Toxicol In Vitro; 2024 Jun; 98():105841. PubMed ID: 38729454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro drug delivery performance of a new budesonide/formoterol pressurized metered-dose inhaler.
    Chambers F; Ludzik A
    J Aerosol Med Pulm Drug Deliv; 2009 Jun; 22(2):113-20. PubMed ID: 19422311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variability in Delivered Dose from Pressurized Metered-Dose Inhaler Formulations Due to a Delay Between Shake and Fire.
    Hatley RH; Parker J; Pritchard JN; von Hollen D
    J Aerosol Med Pulm Drug Deliv; 2017 Feb; 30(1):71-79. PubMed ID: 27635793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug delivery from the Turbuhaler and Nebuhaler pressurized metered dose inhaler to various age groups of children with asthma.
    Agertoft L; Pedersen S; Nikander K
    J Aerosol Med; 1999; 12(3):161-9. PubMed ID: 10623332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.
    Biswas R; Hanania NA; Sabharwal A
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):256-266. PubMed ID: 28157430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case of refractory chronic respiratory tract infection due to Pseudomonas aeruginosa successfully controlled by combination of clarithromycin and azithromycin.
    Yamamoto Y; Izumikawa K; Hosogaya N; Morinaga Y; Nakamura S; Imamura Y; Miyazaki T; Sakamoto N; Ishimatu Y; Kakeya H; Yanagihara K; Yasuoka A; Kohno S
    Intern Med; 2012; 51(11):1383-6. PubMed ID: 22687847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deposition of corticosteroid aerosol in the human lung by Respimat Soft Mist inhaler compared to deposition by metered dose inhaler or by Turbuhaler dry powder inhaler.
    Pitcairn G; Reader S; Pavia D; Newman S
    J Aerosol Med; 2005; 18(3):264-72. PubMed ID: 16181001
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Albuterol delivery from a metered-dose inhaler with spacer is reduced following short-duration manual ventilation in a neonatal ventilator-lung model.
    Lugo RA; Ballard J
    Respir Care; 2004 Sep; 49(9):1029-34. PubMed ID: 15329174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Severe bronchorrhea accompanying alveolar cell carcinoma: treatment with clarithromycin and inhaled beclomethasone].
    Hiratsuka T; Mukae H; Ihiboshi H; Ashitani J; Katoh S; Mashimoto H; Hirosako S; Mizobe T; Matsumoto M; Matsukura S
    Nihon Kokyuki Gakkai Zasshi; 1998 May; 36(5):482-7. PubMed ID: 9742869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients.
    Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.